Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Phase III protocol for tesmilifene accepted by FDA

March 6, 2003

CG-53135 cleared to enter phase I trials

March 6, 2003

Phenoxodiol advances through clinical evaluation

March 5, 2003

Positive opinion in E.U. for long-term use of Zometa

March 5, 2003

Decitabine declared orphan drug for myelodysplastic syndrome in E.U.

March 5, 2003

Direct checkpoint activation: a novel anticancer strategy

March 5, 2003

New enediyne-based metal ligands with utility in cancer and viral infections

March 5, 2003

New antitumor agents in Pharma Mar development pipeline

March 5, 2003

New data on the safety and antitumor effects of ISIS-2503 plus gemcitabine in advanced solid tumors

March 4, 2003

Pharmacia describes inhibitors of beta-catenin/TCF-4 interaction and their use

March 4, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...